MicroRNA-27b-3p Promotes Tumor Progression and Metastasis by Inhibiting Peroxisome Proliferator-Activated Receptor Gamma in Triple-Negative Breast Cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MicroRNA-27b-3p Promotes Tumor Progression and Metastasis by Inhibiting Peroxisome Proliferator-Activated Receptor Gamma in Triple-Negative Breast Cancer
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-08-05
DOI
10.3389/fonc.2020.01371
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Gain Fat—Lose Metastasis: Converting Invasive Breast Cancer Cells into Adipocytes Inhibits Cancer Metastasis
- (2019) Dana Ishay-Ronen et al. CANCER CELL
- Insights into Molecular Classifications of Triple-Negative Breast Cancer: Improving Patient Selection for Treatment
- (2019) Ana C. Garrido-Castro et al. Cancer Discovery
- Aryl hydrocarbon-estrogen alpha receptor-dependent expression of miR-206, miR-27b, and miR-133a suppress cell proliferation and migration in MCF-7 cells
- (2019) Keivan Mobini et al. JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY
- New Insights into the Implication of Epigenetic Alterations in the EMT of Triple Negative Breast Cancer
- (2019) Khaled et al. Cancers
- miR-23b and miR-27b are oncogenic microRNAs in breast cancer: evidence from a CRISPR/Cas9 deletion study
- (2019) Bethany N. Hannafon et al. BMC CANCER
- MicroRNAs Involved in Carcinogenesis, Prognosis, Therapeutic Resistance, and Applications in Human Triple-Negative Breast Cancer
- (2019) Lei Ding et al. Cells
- Triple negative breast cancer: A thorough review of biomarkers
- (2019) Jesse Lopes da Silva et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Suppression of PDHX by microRNA-27b deregulates cell metabolism and promotes growth in breast cancer
- (2018) Steven C. Eastlack et al. Molecular Cancer
- miR-27b-3p inhibits proliferation and potentially reverses multi-chemoresistance by targeting CBLB/GRB2 in breast cancer cells
- (2018) Danni Chen et al. Cell Death & Disease
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Molecular alterations in triple-negative breast cancer—the road to new treatment strategies
- (2017) Carsten Denkert et al. LANCET
- MicroRNAs in the prognosis of triple-negative breast cancer
- (2017) Lingshuang Lü et al. MEDICINE
- MiR-27b is epigenetically downregulated in tamoxifen resistant breast cancer cells due to promoter methylation and regulates tamoxifen sensitivity by targeting HMGB3
- (2016) Xiunan Li et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- EMT: 2016
- (2016) M. Angela Nieto et al. CELL
- HIC1 and miR-23~27~24 clusters form a double-negative feedback loop in breast cancer
- (2016) Yanbo Wang et al. CELL DEATH AND DIFFERENTIATION
- Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease
- (2016) Giampaolo Bianchini et al. Nature Reviews Clinical Oncology
- Ligand-activated PPARγ downregulates CXCR4 gene expression through a novel identified PPAR response element and inhibits breast cancer progression
- (2016) Daniela Rovito et al. Oncotarget
- Rosiglitazone reduces breast cancer risk in Taiwanese female patients with type 2 diabetes mellitus
- (2016) Chin-Hsiao Tseng Oncotarget
- Tumor tissue microRNA expression in association with triple-negative breast cancer outcomes
- (2015) Yan Liu et al. BREAST CANCER RESEARCH AND TREATMENT
- Elevation of miR-27b by HPV16 E7 inhibits PPARγ expression and promotes proliferation and invasion in cervical carcinoma cells
- (2015) SHIMENG ZHANG et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- The MicroRNA-23b/27b/24 Cluster Promotes Breast Cancer Lung Metastasis by Targeting Metastasis-suppressive Gene Prosaposin
- (2014) Brian Ell et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- A Prognostic Model of Triple-Negative Breast Cancer Based on miR-27b-3p and Node Status
- (2014) Songjie Shen et al. PLoS One
- 6-Shogaol inhibits breast and colon cancer cell proliferation through activation of peroxisomal proliferator activated receptor γ (PPARγ)
- (2013) Boon Shing Tan et al. CANCER LETTERS
- Prooncogenic Factors miR-23b and miR-27b Are Regulated by Her2/Neu, EGF, and TNF- in Breast Cancer
- (2013) L. Jin et al. CANCER RESEARCH
- MiR-27b targets PPARγ to inhibit growth, tumor progression and the inflammatory response in neuroblastoma cells
- (2011) J-J Lee et al. ONCOGENE
- Repression of NHE1 Expression by PPAR Activation Is a Potential New Approach for Specific Inhibition of the Growth of Tumor Cells In vitro and In vivo
- (2009) A. P. Kumar et al. CANCER RESEARCH
- ST14(Suppression of Tumorigenicity 14) Gene Is a Target for miR-27b, and the Inhibitory Effect of ST14 on Cell Growth Is Independent of miR-27b Regulation
- (2009) Yanfang Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Suppression of Tumor Formation by a Cyclooxygenase-2 Inhibitor and a Peroxisome Proliferator-Activated Receptor Agonist in an In vivo Mouse Model of Spontaneous Breast Cancer
- (2008) A. Mustafa et al. CLINICAL CANCER RESEARCH
- MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis
- (2008) L.-X. Yan et al. RNA
- PPARγand PPARδas Modulators of Neoplasia and Cell Fate
- (2008) Robert I. Glazer et al. PPAR Research
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search